Safety of Besifloxacin Ophthalmic Suspension 0.6% in Cataract and LASIK Surgery Patients

PURPOSE: The aim of the study was to evaluate the safety of besifloxacin ophthalmic suspension 0.6% as antibacterial prophylaxis in the surgical setting. METHODS: Two prospective safety surveillance studies were conducted—one in the cataract surgery setting and the other in the laser-assisted in sit...

Descripción completa

Detalles Bibliográficos
Autores principales: Majmudar, Parag A., Clinch, Thomas E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cornea 2014
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195578/
https://www.ncbi.nlm.nih.gov/pubmed/24637269
http://dx.doi.org/10.1097/ICO.0000000000000098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195578/
https://www.ncbi.nlm.nih.gov/pubmed/24637269
http://dx.doi.org/10.1097/ICO.0000000000000098

Ejemplares similares